Nature Reviews Drug Discovery 15, 519–521 (2016)
An RXRγ isoform-specific agonist was incorrectly identified as an RXRγ isoform-specific inhibitor. This has now been corrected online.
Additional information
The online version of the original article can be found at 10.1038/nrd.2016.158
Rights and permissions
About this article
Cite this article
Mullard, A. Erratum: Remyelination researchers regroup after proof-of-concept setback in multiple sclerosis. Nat Rev Drug Discov 15, 660 (2016). https://doi.org/10.1038/nrd.2016.172
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd.2016.172
